PureTech Health (LSE:PRTC) Price-to-Tangible-Book : 1.63 (As of May. 19, 2024)

View and export this data going back to 2015. Start your Free Trial

What is PureTech Health Price-to-Tangible-Book?

As of today (2024-05-19), PureTech Health's share price is £2.20. PureTech Health's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was £1.35. Hence, PureTech Health's Price to Tangible Book Ratio of today is 1.63.

The historical rank and industry rank for PureTech Health's Price-to-Tangible-Book or its related term are showing as below:

LSE:PRTC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.44 Med: 1.96 Max: 2.54
Current: 1.63

During the past 12 years, PureTech Health's highest Price to Tangible Book Ratio was 2.54. The lowest was 1.44. And the median was 1.96.

LSE:PRTC's Price-to-Tangible-Book is ranked better than
71.63% of 1230 companies
in the Biotechnology industry
Industry Median: 2.81 vs LSE:PRTC: 1.63

A closely related ratio is called PB Ratio. As of today, PureTech Health's share price is £2.20. PureTech Health's Book Value per Sharefor the quarter that ended in Dec. 2023 was £1.35. Hence, PureTech Health's P/B Ratio of today is 1.63.

PureTech Health Price-to-Tangible-Book Historical Data

The historical data trend for PureTech Health's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Price-to-Tangible-Book Chart

PureTech Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.79

2.30

1.89

1.67

1.44

PureTech Health Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.89	1.04	1.67	1.48	1.44

Competitive Comparison of PureTech Health's Price-to-Tangible-Book

For the Biotechnology subindustry, PureTech Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PureTech Health's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where PureTech Health's Price-to-Tangible-Book falls into.

PureTech Health Price-to-Tangible-Book Calculation

PureTech Health's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.20	/	1.346
	=	1.63

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

PureTech Health Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of PureTech Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

PureTech Health (LSE:PRTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (LSE:PRTC) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PRTC:USA PTCHF:USA PRTCl:UK PRTCL:Germany

Address

6 Tide Street, Suite 400, Boston, MA, USA, 02210

Website

https://www.puretechhealth.com

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.